Clinical Trials in Los Angeles

Showing 2441-2460 of 8,055 trials

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

NCT03940963

Comparing safety, pain, user experience, healthcare economic costs, work productivity, impairment and quality of life outcomes between Axoguard® Nerve Cap and neurectomy in the treatment of symptomatic neuromas in the foot or ankle. Study consists of 86 subjects randomized between the treatment groups followed for 12 months.

Symptomatic NeuromaMorton's NeuromaChronic Nerve Pain

Axogen Corporation86 participantsStarted Oct 2018

Los Angeles, California, United States • Saint Augustine, Florida, United States • Roswell, Georgia, United States +8 more locations

COMPLETEDPhase 2< 1 mile

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

NCT02485938

Male participants with cardiomyopathy secondary to Duchenne muscular dystrophy (DMD) meeting all inclusion and no exclusion criteria will be randomized. All participants will be at least 12 years of age. They will be randomized in a 1:1 manner to either intracoronary infusion of CAP-1002 in three coronary arteries supplying the three major cardiac territories of the left ventricle of the heart (anterior, lateral, inferior/posterior) or usual care. In the active treatment arm, all three major cardiac territories will be treated (infused) during a single procedure in an open-label fashion.

Duchenne Muscular DystrophyCardiomyopathy

Capricor Inc.25 participantsStarted Jan 2016

Los Angeles, California, United States • Gainesville, Florida, United States • Cincinnati, Ohio, United States

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

Find Trials by Condition in Los Angeles

Benefits of Microcor in Ambulatory Decompensated Heart Failure

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Benefits of µCor in Ambulatory Decompensated Heart Failure

PATHFINDER 2: a Multi-Cancer Early Detection Study

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Study of TAK-861 in Participants With Narcolepsy Type 2

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

The Perceptual Experience of Argus II Users

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease